Sarcalumenin Inhibitors
Sarcalumenin inhibitors constitute a class of chemical compounds that have gained recognition in the realm of muscle biology and calcium regulation research. These inhibitors are specifically designed to target and modulate the activity of sarcalumenin, a calcium-binding protein predominantly found in the sarcoplasmic reticulum (SR) of muscle cells. Sarcalumenin is a member of the calsequestrin family and plays a pivotal role in regulating calcium homeostasis within the SR, which is essential for muscle contraction and relaxation. It is involved in the sequestration and release of calcium ions, ensuring precise control over the intracellular calcium levels that govern muscle function.
Sarcalumenin inhibitors exert their effects by interfering with the function or expression of sarcalumenin, disrupting its role in calcium handling within the SR. This interference can lead to alterations in calcium release and uptake kinetics, impacting muscle contractility and relaxation. Researchers employ sarcalumenin inhibitors as valuable tools to investigate the specific roles of sarcalumenin in muscle calcium regulation and to gain insights into the molecular mechanisms underlying excitation-contraction coupling in muscle cells. While the specific applications and broader implications of sarcalumenin inhibitors are subjects of ongoing research, their utility in elucidating the intricate calcium dynamics in muscle physiology is of paramount importance in advancing our understanding of muscle biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By incorporating into RNA and DNA, 5-Azacytidine may inhibit DNA methyltransferase, potentially affecting sarcalumenin gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylase, potentially changing chromatin structure and affecting transcription of the sarcalumenin gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase that regulates protein synthesis and cell growth, potentially downregulating sarcalumenin expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can alter downstream signaling pathways, possibly impacting sarcalumenin synthesis. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Mimics glucose and inhibits glycolysis; this metabolic stress may alter signaling pathways and thus sarcalumenin expression. | ||||||
Mevastatin (Compactin) | 73573-88-3 | sc-200853 sc-200853A | 10 mg 50 mg | $77.00 $179.00 | 18 | |
Mevastatin inhibits HMG-CoA reductase, which could lead to changes in cellular regulatory pathways, potentially affecting sarcalumenin gene expression. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
Chetomin disrupts the function of hypoxia-inducible factor-1, which may lead to altered transcriptional activity affecting sarcalumenin expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor may modify cellular responses to stress and cytokines, potentially influencing sarcalumenin gene transcription. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which might modulate transcription factors and affect the expression of sarcalumenin. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin interferes with protein synthesis at the level of translation, which could indirectly result in decreased sarcalumenin levels. | ||||||